Compare Tilray Brands Inc (TLRY) vs Weyerhaeuser Company Common Stock (WY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tilray Brands Inc vs Weyerhaeuser Company Common Stock — how do they compare? Tilray Brands Inc trades at $3.1 (market cap $463.31M), while Weyerhaeuser Company Common Stock trades at $19.04 (market cap $13.62B). The key difference: Weyerhaeuser Company Common Stock is far larger — about 29.4× Tilray Brands Inc's market cap, and Weyerhaeuser Company Common Stock pays a 4.44% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| TLRY | WY | |
|---|---|---|
Market Cap | $463.31M | $13.62B |
Volume | 4,627,093 | 8,637,043 |
Sector | Health | Real Estate |
52-Week High | $16.80 | $27.10 |
52-Week Low | $3.14 | $18.47 |
Typical Hold Time | 31 Days | — |
Enterprise Value | $617.23M | $18.54B |
Dividend Yield | — | 4.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TLRY trades at $3.27, down 2.68% on the day and near 52-week lows, reflecting persistent bearish pressure. The stock's technical indicators are mixed but overall signal remains negative. Fundamentally, the company reported a net loss of $2.19 billion in 2025 despite $821 million in revenue, with profitability metrics deeply negative. Recent news highlights continued stock weakness and strategic brand expansions under Tilray ownership.
The outlook is highly speculative; TLRY faces significant execution and profitability challenges, though analyst consensus suggests substantial upside potential from current levels. Key risks include ongoing losses, high debt levels, and regulatory uncertainty in the cannabis sector. Investment suitability is limited to high-risk tolerance investors betting on a operational turnaround or favorable regulatory shifts.
Weyerhaeuser (WY) trades at $18.97, up 0.16% with neutral technical signals. The stock shows strong earnings momentum, beating estimates for three consecutive quarters, while fundamentals reveal modest profitability with 6.89% net margin and 4.97% ROE. Recent news highlights institutional accumulation and upcoming Q3 earnings on October 29. The company maintains stable revenue at $6.9B but faces cash flow challenges with negative net cash flow of $203M in 2025.
Weyerhaeuser presents a mixed outlook with analyst consensus favoring bullish sentiment (52% buy ratings) and a $29.33 price target suggesting 55% upside. However, risks include weak dividend coverage, high leverage at 5x, and sensitivity to interest rates and housing market cycles. The stock's current proximity to 52-week lows offers potential value but requires careful monitoring of lumber demand recovery and Q3 earnings results.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →About Weyerhaeuser Company Common Stock
Weyerhaeuser Company is a timberland-focused real estate investment trust (REIT) that owns and manages more than 10 million acres of timberland in US, in addition to timberlands under long-term license in Canada. The company also manufactures wood products, including lumber, oriented strand board, and engineered wood.
Read more on WY →
